INTRODUCTION {#s1}
============

The existence of bidirectional communication between the gut and brain has long been established. Recently, a body of work has suggested that the commensal gut microbiota plays an important role in modulating the gut-brain axis, possibly through immune, endocrine, and neural system pathways ([@R1]). This has led to increased interest in modulating the gut microbiota to target central nervous system (CNS) functions and improve human behavior especially in areas such as stress, mood, anxiety, and cognition. Probiotics may represent a safe and effective way of targeting CNS function. Indeed, an abundance of preclinical studies have shown that probiotics acting through the gut-brain axis can affect brain development, function, and behavior ([@R2]). However, the translation of promising preclinical signals into human subjects with certain probiotic strains has proven challenging ([@R3]). Therefore, there is a need for more detailed mechanistic insights into the interaction between the gut microbiota and brain function in humans.

One probiotic strain, *Bifidobacterium longum* 1714™ (Zenflore), has proven effective in modulating CNS functions in animals and humans. *B. longum* 1714™ has been shown to reduce stress-related behaviors in preclinical studies ([@R4],[@R5]) and improve stress responses and cognitive function in healthy volunteers ([@R6]). However, the role of *B. longum* 1714™ in modulating brain function in humans is unclear. Clinical studies with probiotics using neuroimaging methods have started to emerge and provide insight into modulations of CNS functions in healthy volunteers ([@R7]--[@R9]) and in patients with irritable bowel syndrome (IBS) ([@R10]). The first study to demonstrate neural effects of probiotics in humans used functional MRI and showed that brain activations to emotional faces were altered by a 4-week consumption of a fermented dairy drink in comparison to placebo in healthy subjects ([@R7]). A more recent study in healthy volunteers showed positive correlations between psychometric measures and brain activity ([@R8]) as well as altered functional connectivity ([@R9]) in response to emotional processing after a 4-week intervention with a multi-strain probiotic. Of interest, treatment of patients with IBS using *B. longum*™ NCC3001 for 6 weeks resulted in an improvement in depressions scores and reduction in limbic activity to negative emotional stimuli, but had no effect on gut symptoms ([@R10]). Notably, these previous studies used picture-viewing tasks during brain recording that poorly reflect behavioral changes found in animal models, which are commonly used to screen the effects of probiotics on stress and emotions. Furthermore, both studies in healthy volunteers used multi-strain probiotic product making it difficult to identify the bacterial strain responsible for the observed effects and the pathways involved in strain-specific effects. Therefore, further investigations are required using targeting approaches and different stress paradigms.

In this study, we explored the effect of *B. longum* 1714™ on brain function in response to social stress in a randomized, double-blinded, placebo-controlled trial, using the neuroimaging method magnetoencephalography (MEG). Social stress was induced by social exclusion/rejection ([@R11]) through a standardized paradigm, called "Cyberball Game" (CBG) ([@R12]). According to a recent review summarizing previous neuroimaging studies on the CBG, regions of the prefrontal cortex (PFC), anterior cingulate cortex (ACC), and temporal cortex are involved in neural processing of this type of social stressor ([@R13]). Indeed, social stress during the CBG is consistently associated with altered neural oscillations in certain brain areas, such as alpha band power in frontal cortex and theta band power in the ACC and insula ([@R14]--[@R17]).

In the current trial, we hypothesized that the probiotic strain *B. longum* 1714™ alters resting-state brain activity and neurophysiological responses to CBG-induced social stress. We assumed that during the CBG, stress-related neural oscillations of the theta and alpha band power would be changed after probiotic treatment. The results confirmed that *B. longum* 1714™ modulated neural responses during social stress, suggesting counter-regulation of negative emotions.

METHODS {#s2}
=======

Participants {#s2-1}
------------

Healthy adults were recruited to the study. Criteria for inclusion were (i) man or woman aged 18--50 years; (ii) nonsmoker for at least 3 months; (iii) a body mass index of 18--30; (iv) no chronic allergies; (v) willing to discontinue their normal consumption of probiotics and probiotic-containing foods or potentially immune-enhancing dietary supplements; (vi) receiving no immune-suppressing intervention and not having any immunosuppressive illness within the past year; (vii) receiving no antibiotic therapy within the past 2 months; (viii) having no chronic psychiatric or gastrointestinal disorder; and (ix) having no nonremovable metal parts in the body. Informed consent was obtained from all participants before joining the study. Participants were screened for IBS and psychiatric disorders using the Rome III criteria ([@R18]) and the Patient Health Questionnaire ([@R19]). During the intervention period, participants were instructed to avoid consumption of food containing probiotics/prebiotics or potentially immune-enhancing dietary supplements. This was supported by providing them with a list of "prohibited" foods (see Information 1, Supplementary Digital Content 1, http://links.lww.com/AJG/A163). Demographic and baseline psychological information was also recorded. The protocol was approved by the Ethics Board of the University of Tübingen Medical School (No. 503/2015BO1, as of August 26, 2015) and registered at [ClinicalTrials.gov](http://ClinicalTrials.gov) (identifier No. NCT02793193).

Design {#s2-2}
------

A randomized, double-blinded, parallel-group design was used. After screening, participants were randomly allocated to the probiotic or placebo group for 4 weeks. At baseline (visit 1) and 1 day after completion of the intervention period (visit 2), measurements of resting-state MEG, MEG during CBG, and related questionnaires to measure the level of distress were performed. Structural MR images were acquired on a different day, regardless of the intervention schedule. To record participants health and quality of life status, participants completed the 36-item short-form health survey (SF36) ([@R20]) at the beginning of each of the 2 visits. The SF36 includes 8 subscales: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/vitality, and general health perceptions. The randomization scheme was only unblinded after completion of the experiment and complete data evaluation.

Materials {#s3}
---------

The probiotic and placebo preparations were provided by Alimentary Health Group, Cork, Ireland. Participants were randomized to receive sachets containing either probiotic (1 × 10^9^ CFU of *B. longum* 1714™ in 2 g of maltodextrin) or placebo (2 g of maltodextrin). Probiotic and placebo were identically packaged. Participants were instructed to consume one sachet every morning by mixing the content into 50 mL of water. Both subjects and investigators were blinded to the regime administered.

CBG {#s3-1}
---

The CBG was used to study the effects of social stress and exclusion as outlined previously by Wang et al. ([@R21]). Briefly, during the CBG, participants were asked to play a virtual ball-tossing game with 2 other virtual players programmed. The CBG involves 2 conditions, the so-called inclusion and exclusion. Figure [1](#F1){ref-type="fig"} presents a single trial from 1 player throwing the ball to another (Figure [1](#F1){ref-type="fig"}) (see Information 2, Supplementary Digital Content 1, http://links.lww.com/AJG/A163 for more detail).

![Schematic outline of a trial in the Cyberball Game (CBG).](acg-114-1152-g001){#F1}

CBG questionnaires {#s3-2}
------------------

After the CBG exclusion or inclusion periods, participants completed 3 questionnaires to assess the level of acute distress. We employed the self-report measures of the Need Threat Scale (NTS), the Mood Questionnaire (MQ), and the Subjective "Exclusion Perception" (SEP) (see Information 3, Supplementary Digital Content 1, http://links.lww.com/AJG/A163); all these scales are validated standards for the CBG ([@R12],[@R22]). The NTS is designed to measure the feelings and emotional consequences of social rejection, and higher scores related to higher distress level. Its 4 items (rated between 1 and 5 for "weak" to "strong") comprised self-esteem, belonging, meaningful existence, and control, and combined ratings have been used as a measure of social distress in previous studies. The MQ is used to assess mood, using 8 questions (are you feeling bad, good, happy, sad, pleasant, angry, friendly, and unfriendly), all rated between 1 and 5. The SEP is used to record participants\' feeling of being included/ostracized by asking them to rate 2 statements ("I was ignored" and "I was excluded") between 1 and 5.

MEG recording {#s3-3}
-------------

Brain magnetic fields were measured with a 275-channel whole-head MEG (CTF Omega, Port Coquitlam, Canada). Participants were studied in sitting position. During each session, 5 minutes resting state was recorded before playing the CBG. During the resting state, participants were instructed to move as little as possible and to stay alert while keeping their eyes closed. During the CBG, task instructions were projected onto a screen in front of the participants using a video projector and a mirror system. MEG signals were sampled at a rate of 585.94 Hz with an anti-aliasing filter set to 146.49 Hz.

To overlay the brain activity derived from MEG on anatomical scans, high-resolution (1 mm, isotropic) T1-weighted structural MR images were acquired using an MPRAGE sequence with a Siemens MAGNETOM Trio 3T scanner (Siemens AG, Erlangen, Germany) (12-channel array head coil) for each participant, but at a separate occasion.

Data analysis {#s3-4}
-------------

### Power calculation. {#s3-4-1}

The primary endpoint was change in brain activity. Based on previously published data ([@R7]), we estimated that---with a power of 0.95 for a 2 × 2 repeated measure ANOVA---a minimum sample size of 28 was required to demonstrate an effect size *f* = 0.23 at α = 0.05 in a parallel-group designed study (see Information 4, Supplementary Digital Content 1, http://links.lww.com/AJG/A163 for more detail).

Data analysis: MEG {#s3-5}
------------------

Analysis of the MEG data was performed using MATLAB (Mathworks, Natick, MA) and the open-source toolboxes FieldTrip ([@R23]). Data from the resting state and during the CBG were analyzed, respectively, after procedures of preprocessing (trial segmentation and artifacts rejection)---Time-frequency analysis (multitaper windowed fast Fourier transform)---Source analysis (dynamic imaging of cortical sources: DICS)---Source statistics (cluster-based permutation statistics).

Data analysis: Questionnaires {#s3-6}
-----------------------------

Data analysis was conducted using SPSS 21 (IBM, Armonk, NY). To examine whether there was a significant difference in health status between groups at baseline, scores of SF36 during the first visit were entered into a nonparametric independent-sample Mann-Whitney *U* test of *Intervention* as between factor (*B. longum* 1714™ vs placebo) because parametric assumptions of these data were violated. To test the intervention-related changes in participants\' health status scored by SF36, changes from before to after the 4-week intervention were computed by subtracting the baseline assessment from the corresponding postintervention values. A nonparametric two-way independent-sample Mann-Whitney *U* test was used to examine the change of SF36 between Intervention (*B. longum* 1714™ vs placebo).

To examine whether subjective ratings for the CBG were different between groups at baseline, scores of NTS, MQ, and SEP acquired during the first visit were entered into an independent *t* test with Intervention as between factor (*B. longum* 1714™ vs placebo). To control the intervention-related changes in the scores of the NTS, MQ, and SEP during the CBG, changes after each intervention were computed for each condition and entered into a 2 × 2 repeated measure ANOVA with Intervention as a between-factor (*B. longum* 1714™ vs placebo) × *Condition* as a within-factor (exclusion vs inclusion). Where significant main effects or interaction were observed, pairwise post hoc comparisons were used with a Bonferroni-adjusted threshold (α = 0.025). Mean data are reported as M ± s.d.

Correlation between stress measures and quality of life assessments with MEG data {#s3-7}
---------------------------------------------------------------------------------

To investigate the relationship between changes in neural activity and changes in subjective scores induced by *B. longum* 1714™, correlation analysis was performed for both, the change in brain activity in the resting state and after the CBG. For the resting state, averaged source power was calculated for the clusters that were significantly different between both visits. The averaged source power was correlated with changes in health status (SF36) for each group separately. For the CBG, for each condition and each intervention, source power within clusters significantly different between both visits was averaged. The averaged source power was correlated with changes in the scores of the NTS, MQ, and SEP separately for each condition and each group, using Pearson correlations.

RESULTS {#s4}
=======

Subjects and baseline characteristics {#s4-1}
-------------------------------------

A total of 40 healthy volunteers completed the study. After screening, 43 subjects were randomized to either *B. longum* 1714™ or placebo. Three subjects could not be included in the final analysis because of use of antibiotics during the intervention period (Figure [2](#F2){ref-type="fig"} for detailed trial profile). A total of 40 participants were included in the analysis with n = 20 per intervention group. Sex of participants was matched between groups. Age and body mass index of participants were not significantly different between groups (Table [1](#T1){ref-type="table"} for details).

![The CONSORT flow diagram of the clinical trial. Reprinted from Schulz et al. Copyright BMJ ([@R48]). All permission requests for this image should be made to the copyright holder.](acg-114-1152-g002){#F2}

###### 

Demographic and baseline information

![](acg-114-1152-g003)

Administration of social stress ("CBG") altered brain activity in healthy volunteers at baseline {#s4-2}
------------------------------------------------------------------------------------------------

At baseline, stress effects were analyzed across all participants. No difference between groups at baseline during rest was observed in any frequency band. As expected, source statistics of MEG power in each frequency band showed brain regions that had significantly different activities during the exclusion compared with the inclusion condition (Figure [3](#F3){ref-type="fig"}). The global NTS (*t*~37~ = 13.39, *P* \< 001) and SEP (*t*~38~ = 9.99, *P* \< 001) scores were significantly higher, and the MQ scores (*t*~39~ = −9.42, *P* \< 001) were lower in the exclusion condition compared with inclusion condition (Table [1](#T1){ref-type="table"}). At baseline, there were no significant differences in SF36 scores or CBG subjective scores (NTS, MQ, and SEP) after the social stress between groups (Table [1](#T1){ref-type="table"}).

![Neural activities in different frequency bands during exclusion vs inclusion condition. (**a**) Theta frequency band (6 Hz): increased power in the bilateral cerebellum (CBL), right middle and inferior frontal cortex (MFC and IFC), left fusiform cortex (*P* = 0.004); decreased power in the left middle frontal and bilateral superior frontal cortex (SFC) (*P* = 0.02). (**b**) Alpha frequency band (11 Hz): increased power in the bilateral CBL, left fusiform, right inferior occipital cortex (*P* = 0.002); decreased power in the right SFC (*P* \< 0.05). (**c**) Beta-1 frequency band (16 Hz): increased power in the bilateral CBL, left MFC, left inferior temporal, right middle and superior temporal cortex, and right parahippocampal (*P* = 0.004). (**d**) Beta-2 frequency band (21 Hz): increased power in the right CBL, left IFC, right inferior and middle temporal cortex (MTC) (*P* = 0.002). (**e**) Beta-3 frequency band (26 Hz): increased power in the bilateral CBL, right fusiform, left parahippocampal, left MTC (*P* = 0.04).](acg-114-1152-g004){#F3}

*B. longum* 1714™ altered resting-state brain activity measured by MEG {#s4-3}
----------------------------------------------------------------------

After a 4-week intervention, comparison between probiotic and placebo group showed that *B. longum* 1714™ feeding increased theta band (6 Hz) power (*P* \< 0.05; Figure [4](#F4){ref-type="fig"}a) in the bilateral inferior, middle, and superior frontal cortex (IFC, MFC, and SFC) as well as in the bilateral anterior and middle cingulate cortex (ACC and MCC). Furthermore, feeding *B. longum* 1714™ reduced beta-2 band (26 Hz) power (*P* \< 0.05; Figure [4](#F4){ref-type="fig"}b) in the bilateral fusiform gyrus, the bilateral hippocampus, the left inferior and superior temporal and bilateral middle temporal cortex, and the left cerebellum.

![Difference of neural activity change during resting state comparing *B. longum* 1714™ vs placebo. (**a**) After the intervention, an increased theta band (6 Hz) power was obtained in a cluster including regions of bilateral inferior frontal cortex, middle frontal cortex, and the bilateral anterior cingulate cortex and middle cingulate cortex, comparing *B. longum* 1714™ with the placebo group (*P* \< 0.05). (**b**) After the intervention, reduced beta-2 band (26 Hz) power was obtained in a cluster, consisting of the bilateral fusiform gyrus and hippocampus, left inferior temporal cortex and superior temporal cortex, bilateral middle temporal cortex and left cerebellum, comparing *B. longum* 1714™ with the placebo group (*P* \< 0.05).](acg-114-1152-g005){#F4}

*B. longum* 1714™--induced change in neural activity correlated with increased vitality {#s4-4}
---------------------------------------------------------------------------------------

No significant difference was found in changes of SF36 scores after intervention between groups. To investigate the relationship between changes in neural activity during resting state and quality of life, the changes in averaged theta and beta-2 band power with changes in SF36 scores were correlated. In both groups, a significant positive correlation was obtained between changes of the SF36 subscale "Energy/Vitality" with changes of theta band power (*r* = 0.33, *P* = 0.04; Figure [5](#F5){ref-type="fig"}a). Group-specific correlations revealed that only in the *B. longum* 1714™ group, changes in SF36 score for "Energy/Vitality" positively correlated with changes in averaged theta band power (*r* = 0.61, *P* = 0.007), and negatively correlated with changes in beta-3 band power during the resting state (*r* = −0.50, *P* = 0.04; Figure [5](#F5){ref-type="fig"}b).

![Correlation between neural activity change during resting state and SF36 change. (**a**) In all groups, a positive correlation was obtained between changes of SF36 item "Energy/vitality" with changes of theta band power in the cluster (*r* = 0.33, *P* = 0.04). (**b**) In only *B. longum* 1714™ group, changes of SF36 item "Energy/vitality" positively correlated with change of averaged theta band power (*r* = 0.61, *P* = 0.007), and negatively correlated with change of beta-3 band power in the activated clusters during the resting state, respectively (*r* = −0.50, *P* = 0.04). SF36, 36-item short-form health survey.](acg-114-1152-g006){#F5}

All groups reported enhanced social stress measured by subjective ratings after a 4-week intervention {#s4-5}
-----------------------------------------------------------------------------------------------------

Analysis of changes in NTS, MQ, and SEP scores showed significant main effects of condition on NTS (*F* (1, 33) = 5.91, *P* = 0.02) and on SEP (*F* (1, 36) = 5.61, *P* = 0.02) as determined by ANOVA (Intervention × Condition). Participants in all groups reported increased scores of NTS (exclusion: M = 5.20 ± 2.37; inclusion: M = −4.32 ± 1.85) and SEP (exclusion: M = 0.94 ± 0.42; inclusion: M = −0.30 ± 0.16) in the exclusion compared with inclusion condition, after 4 weeks of intervention. The changes in MQ scores (exclusion: M = −1.87 ± 1.08; inclusion: M = 0.30 ± 0.86) showed no difference after intervention (*F* (1, 34) = 1.72, *P* = 0.20) (Figure [6](#F6){ref-type="fig"}). There were no effects of intervention on the subjective scores of these questionnaires (Table [2](#T2){ref-type="table"}).

![Main effects of condition on NTS and SEP. Participants in all groups reported increased scores of NTS and SEP in the exclusion condition compared with inclusion condition, after a 4-week intervention. MQ, mood questionnaire; NTS, Need Threat Scale; SEP, subjective exclusion perception.](acg-114-1152-g007){#F6}

###### 

Changes in subjective scores of SF36, NTS, MQ, and SEP

![](acg-114-1152-g008)

*B. longum* 1714™--altered brain activity during social stress measured by MEG {#s4-6}
------------------------------------------------------------------------------

After a 4-week intervention, *B. longum* 1714™ induced changes in source power in theta (6 Hz) band and alpha band (11 Hz) in response to the CBG, compared with placebo. *B. longum* 1714™ increased theta band power in 1 cluster, consisting of the right IFC and the bilateral MFC and SFC, the left ACC, the bilateral MCC, and the right supramarginal gyrus in both conditions---inclusion and exclusion (*P* = 0.03; Figure [7](#F7){ref-type="fig"}a). Furthermore, *B. longum* 1714™ also increased the alpha band power in the cluster, including regions of the right IFC, the bilateral MFC and SFC, the bilateral ACC and MCC, and the right supramarginal gyrus in both conditions (*P* = 0.04; Figure [7](#F7){ref-type="fig"}b). No main effects of condition or interaction of intervention and condition were observed.

![Difference in neural activity change during the Cyberball game comparing *B. longum* 1714™ vs placebo. (**a**) Theta band showed an increased power in a cluster, consisting of the right inferior frontal cortex (IFC) and the bilateral middle frontal cortex (MFC) and superior frontal cortex (SFC), the left anterior cingulate cortex (ACC), the bilateral middle cingulate cortex (MCC), and the right supramarginal gyrus (SMG), comparing *B. longum* 1714 group and the placebo group in both conditions (*P* = 0.03). (**b**) Alpha band power also showed an increased power in cluster, including regions of the right IFC, the bilateral MFC and SFC, the bilateral ACC and MCC, and the right SMG, comparing *B. longum* 1714™ group and the placebo group in both conditions (*P* = 0.04). No main effects of condition or interaction of intervention and condition were observed.](acg-114-1152-g009){#F7}

*B. longum* 1714™--induced change in neural activity in social stress correlated with changes in distress levels {#s4-7}
----------------------------------------------------------------------------------------------------------------

Correlation analysis between changes in neural activities and changes in subjective ratings during the CBG revealed that only with *B. longum* 1714™ and only during the exclusion condition, NTS changes positively, correlated with changes in the theta band power (*r* = 0.62, *P* = 0.008) and alpha band power (*r* = 0.54, *P* = 0.03; Figure [8](#F8){ref-type="fig"}).

![Correlation between neural activity change during the Cyberball game and subjective score changes. Only in *B. longum* 1714™ group and only during the exclusion condition, NTS changes positively correlated with changes of the theta band power (*r* = 0.62, *P* = 0.008) and alpha band power (*r* = 0.54, *P* = 0.03). NTS, Need Threat Scale.](acg-114-1152-g010){#F8}

Summaries of frequency bands and neuroanatomical areas found to be related to *B. longum* 1714™ intervention, and associations of changes in neural activity and subjective effects are provided in Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}, respectively.

###### 

Summarized neuroanatomical areas and frequency bands of changed neural activities influenced by effect of condition, intervention and/or interaction of condition and intervention

![](acg-114-1152-g011)

###### 

Summarized correlations of changes of averaged power in activated areas with changes of subjective results

![](acg-114-1152-g012)

DISCUSSION {#s5}
==========

*B. longum* 1714™ has been shown to reduce stress-related behaviors in preclinical studies ([@R4],[@R5]) and improve stress responses and cognitive function in healthy volunteers ([@R6]). The current functional neuroimaging study showed that *B. longum* 1714™ significantly altered neural activities in the resting state and in response to a social stressor in healthy participants after a 4-week intervention. The alteration in the resting brain activity by *B. longum* 1714™ was associated with the SF36 scale "Energy/Vitality." In response to the social stress, the changed neural activities occurred only in the probiotic group. These data suggest that *B. longum* 1714™ may play a role in managing stress responses by modulating the relevant neural processes.

During the resting state, *B. longum* 1714™ induced an increase in theta band power in the frontal and cingulate cortex and a decrease in beta-3 band power in the fusiform cortex, hippocampus, temporal cortex, and cerebellum. Although no significant change of SF36 was noted after the 4-week probiotic intake, the increase in theta band and decrease in beta-3 band power found in the resting state was associated with increase in perceived energy/vitality levels, as assessed by the SF36. Energy/vitality in the SF36 measures subjective reception of participants---how full of pep and energetic they felt. Other studies have shown an association between increased power in theta band (whole brain, especially prominent in the frontal regions) on a resting-state EEG with improved attention and arousal after consumption of glucose ([@R24],[@R25]) whereas decreased theta band power measured by MEG in cingulate cortex has been correlated with subjective level of fatigue ([@R26]). Of interest, an increase in beta band power has been linked to mental fatigue ([@R27]), and inversely, reduced beta power could index increased alertness and arousal, accompanied with decreased anxiety and stress ([@R28],[@R29]). These data suggest that *B. longum* 1714™ altered neural activities in a manner associated with enhanced vitality and reduced mental fatigue.

From an evolutionary perspective, humans are programmed to be highly sensitive to social exclusion and have developed monitoring systems to detect cues ([@R30],[@R31]). This is necessary for human survival as social isolation is often a fatal threat ([@R32],[@R33]). As expected, the CBG induced a social stress effect at baseline across all participants. Social exclusion produced differential neural oscillations in all frequency bands in various areas, such as frontal, temporal, and fusiform cortex. These results were similar to previous EEG and MEG studies, showing modulation of neural oscillations by social exclusion ([@R14],[@R15],[@R17],[@R21]). Previously reported ACC activations were related to processing of negative emotions and event appraisal due to the social stress/exclusion, and PFC activation was related to emotional regulation ([@R13],[@R34]--[@R36]). Theta band oscillations in ACC and insula were described as a marker of social pain in the context of the CBG and was also found during a cold pressor test and physical pain ([@R37],[@R38]). The participants reported enlarged subjective distress and decreased mood level during the exclusion condition compared with the inclusion condition, consistent to previous studies ([@R12],[@R14],[@R15],[@R17]). After the intervention, as expected, all participants reported higher distress level during the exclusion condition compared with the inclusion condition after 4 weeks, regardless of the type of intervention (probiotic, placebo). However, a clinical effect of *B. longum* 1714™ on reducing stress was not observed---the study was not powered to detect differences in subjective stress. Furthermore, as with other stress paradigms, the repetition of stress may reinforce the feeling of being excluded and consolidated the memory of the stressful event making it difficult to detect differences with small numbers.

Although both placebo and probiotic groups reported higher subjective distress, changes in neural processing of social stress were observed only after *B. longum* 1714™ consumption and not placebo. In addition, the correlation between changes in subjective distress and neural activities was seen only with *B. longum* 1714™. Therefore, these data support the notion that *B. longum* 1714™ may play a role in managing stress responses by modulating the relevant neural processes; *B. longum* 1714™ affecting individuals\' neurophysiology is a novel finding and was previously only reported for behavioral data in animals and humans ([@R4]--[@R6]).

However, in comparison to other neurophysiological studies with the CBG ([@R22],[@R23]), our study involved repeated exposure to the social stress 4 weeks apart. Indeed, similar changes in theta band activity induced by *B. longum* 1714™ were observed in the resting-state data (before playing the CBG) of the current study, which correlated with increased vitality. These data suggest that the increase in theta and alpha band power by *B. longum* 1714™ before the stressor may be to some degree a priming for the stressor and may represent an upregulation of appraisal processes and coping mechanisms in the expectation of being exposed to a similar stressful situation again. Furthermore, lower frontal alpha power has been associated with anxiety ([@R39],[@R40]). The increased alpha oscillation activity in our study may indicate the inhibition of limbic activity and thereby counter-regulate negative emotions and stress. Taking this argument further, we suggest that in contrast to placebo, *B. longum* 1714™ reduced participants\' stress response and enabled them to manage the increased distress level by upregulating processes appraising stressful events and downregulating negative emotions.

Other studies, in line with our data, showed neural modulation by different psychobiotic strains, and provided some clues of the potential mechanisms involved. Preclinical studies have reported an increase in serotonin and dopamine level, 2 crucial neurotransmitters regulating mood and emotions, in brain regions of mice such as PFC after interventions with *Lactobacillus plantaraum* and *Lactobacillus helveticus* ([@R41]--[@R43]). Another study showed *Lactobacillus rhamnosus* JB-1 modulated GABAergic system and reduced stress-related psychiatry-like behaviors in mice, and some of the effects were mediated by the vagus nerve ([@R44]). However, effects of the *L. rhamnosus* JB-1 were not found in a clinical study in healthy volunteers, indicating possibly the challenge of translating preclinical studies into clinical relevance ([@R3]). The lack of evidence of translating preclinical to clinical studies was also addressed by a recent meta-analysis on the anxiolytic effect of probiotics ([@R45]), suggesting a need to investigate strain specificity and use functional imaging techniques in clinical studies in alternative to subjective questionnaires.

In our recent study, antistress effects of rifaximin on social stress were associated with a reduction of frontal and cingulate beta band power in the insula, frontal and cingulate gyrus, after 1-week intervention ([@R21]). Although causing a stress reduction like *B. longum* 1714™, rifaximin may act through different pathways---different neural oscillations and brain regions. Because the peripheral and central mechanisms by which rifaximin affects stress management are not well understood, one may speculate on an "eubiotic" effect of this antibiotic promoting beneficial bacteria such as *Bifidobacteria* and *Lactobacilli* ([@R46],[@R47]). Therefore, although effects of probiotics on CNS functions appear to be strain-specific ([@R4]), results of existing studies help to understand the possible pathways of the strain we used in the current trial. More studies are required to investigate the effects of different strains on diverse brain activities in response to stress in order to obtain a detailed picture of the effects of probiotics on brain functioning.

CONCLUSION {#s6}
==========

*B. longum* 1714™ influenced resting neural activities associated with enhanced vitality and stress-related neural responses, which may be involved in the counter-regulation of negative emotions. Our results further support the role of *B. longum* 1714™ in reducing stress responses and provides new evidence that this probiotic affects brain function through modulating neural oscillations in certain brain regions. The understanding of neural oscillations induced by stress and their modulation by probiotics is still at its beginning. Studies that examine the mechanisms by which probiotics modulate the gut-brain axis and compare their effects on other CNS functions with other interventions are warranted. To fully understand the effects of *B. longum* 1714™ on brain function and human behavior, it is necessary to consider the effects of the strain on other CNS functions such as pain sensitivity, mood, and memory in both healthy controls and in patients with psychiatric (depression, anxiety), neurologic (neurodegenerative), and gastrointestinal disorders such as IBS.
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###### Study Highlights

WHAT IS KNOWN
-------------

✓ Accumulating evidence indicates that the gut microbiota communicates with the CNS, possibly through neural, endocrine, and immune pathways, and influences brain function.✓ Effects of probiotics on the CNS functions are strain specific.✓ *B. longum* 1714™ has been shown to reduce stress-related behaviors in preclinical studies and improve stress responses and cognitive function in healthy volunteers.

WHAT IS NEW HERE
----------------

✓ *B. longum* 1714™ altered brain activity of healthy volunteers during social stress as measured by neuroimaging method MEG with high temporal resolution and fine spatial resolution.✓ *B. longum* 1714™ influenced resting neural activities associated with enhanced vitality and stress-related neural responses, which may be involved in the counter-regulation of negative emotions.✓ Our results further support the role of *B. longum* 1714™ in reducing stress responses in humans and provides new evidence that this probiotic strain affects brain function through modulating neural oscillations in brain regions involved in emotional regulation.
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**SUPPLEMENTARY MATERIAL** accompanies this paper at http://links.lww.com/AJG/A163
